Institutional Ownership Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX). We have compiled data on the 294 institutions that hold shares in the stock, with a total of 66.9 Million shares, which have been reported (via 13F filing form) to have a value of $5.66 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Farallon Capital Management LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
6,196,006
shares
|
$524 Million
1.78% of portfolio
|
Q3 2025
Added 0.39%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,758,112
shares
|
$487 Million
0.0% of portfolio
|
Q2 2024
Added 3.39%
|
|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
5,756,277
shares
|
$487 Million
5.11% of portfolio
|
Q2 2025
Added 0.64%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
4,257,229
shares
|
$360 Million
0.0% of portfolio
|
Q3 2025
Reduced 2.33%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
3,165,795
shares
|
$268 Million
0.01% of portfolio
|
Q3 2025
Reduced 1.3%
|
|
|
Bvf Inc
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
2,560,916
shares
|
$217 Million
9.2% of portfolio
|
Q3 2025
Reduced 20.25%
|
|
|
Johnson & Johnson
New Brunswick, NJ |
Nov 13, 2025 Q3 2025 |
2,449,183
shares
|
$207 Million
38.07% of portfolio
|
Q3 2021
New holding
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
1,908,446
shares
|
$161 Million
0.02% of portfolio
|
Q3 2025
Added 83.9%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
1,896,008
shares
|
$160 Million
0.02% of portfolio
|
Q3 2025
Reduced 24.2%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
1,715,691
shares
|
$145 Million
3.6% of portfolio
|
Q3 2025
Reduced 47.14%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
1,438,247
shares
|
$122 Million
0.49% of portfolio
|
Q3 2025
Added 51.89%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,416,646
shares
|
$120 Million
0.01% of portfolio
|
Q3 2025
Reduced 1.91%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
1,220,436
shares
|
$103 Million
0.01% of portfolio
|
Q3 2025
Added 30.29%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,139,854
shares
|
$96.4 Million
0.64% of portfolio
|
Q3 2025
Added 50.43%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
1,100,821
shares
|
$93.1 Million
0.04% of portfolio
|
Q3 2025
Added 146.36%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
1,085,564
shares
|
$91.8 Million
0.08% of portfolio
|
Q3 2025
New holding
|
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,030,134
shares
|
$87.2 Million
0.15% of portfolio
|
Q3 2025
Reduced 4.12%
|
|
|
Commodore Capital LP
New York, NY |
Nov 14, 2025 Q3 2025 |
1,025,000
shares
|
$86.7 Million
4.35% of portfolio
|
Q3 2025
Reduced 4.65%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
1,003,706
shares
|
$84.9 Million
0.01% of portfolio
|
Q3 2025
Added 39.08%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
989,182
shares
|
$83.7 Million
6.17% of portfolio
|
Q3 2025
Added 4.34%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
829,877
shares
|
$70.2 Million
0.0% of portfolio
|
Q3 2025
Reduced 2.58%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 18, 2025 Q3 2025 |
822,212
shares
|
$69.6 Million
0.06% of portfolio
|
Q3 2025
Added 9.34%
|
|
|
Jefferies Financial Group Inc.
New York, NY |
Nov 12, 2025 Q3 2025 |
821,503
shares
|
$69.5 Million
0.27% of portfolio
|
Q3 2025
Reduced 0.31%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
781,711
shares
|
$66.1 Million
0.01% of portfolio
|
Q3 2025
Added 0.57%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
768,359
shares
|
$65 Million
0.0% of portfolio
|
Q3 2025
Reduced 11.58%
|
|